ALS Groups Unite to Fund Bold, High-Risk Research

LOS ANGELES, CA – March 16, 2026 – In a significant move to accelerate the fight against amyotrophic lateral sclerosis (ALS), the ALS Network and ALS United today announced a joint call for research proposals, seeking to fund what they describe as “bold” and “imaginative” science. The initiative represents a strategic pooling of resources aimed at breaking through persistent barriers in understanding and treating the devastating neurodegenerative disease.

From March 16 through April 20, 2026, the organizations will accept Letters of Intent (LOIs) for their expanded ALS Research Innovation Initiative. This call for proposals is not just another funding cycle; it is a deliberate effort to attract unconventional ideas and high-risk, high-reward projects that might otherwise struggle to secure backing through traditional channels. The partnership underscores a growing consensus in the medical research community: tackling complex diseases like ALS requires a united front.

The Power of a United Front

Collaboration is the central theme of this new initiative. "Collaboration is essential to changing the course of ALS," said Sheri Strahl, President and CEO of the ALS Network, in the official announcement. "Through partnerships like this with ALS United, we are able to invest in promising ideas and empower researchers who are working to unlock new possibilities for people living with this devastating disease."

This alliance is more than a one-time project. The ALS Network is a key member of the broader ALS United collaborative, a national framework of organizations working in concert. This structure allows for amplified impact, combining financial resources, research expertise, and community outreach. It reflects a larger trend in biomedical research where isolated efforts are giving way to large-scale, cooperative ventures. Organizations like the Northeast ALS Consortium (NEALS) and Target ALS have already demonstrated the power of breaking down silos to accelerate drug and biomarker development.

By joining forces, the ALS Network and ALS United can offer more substantial support and create a more efficient review process, ensuring that the most promising science gets funded quickly. The initiative will award grants of up to $150,000, which can serve as critical seed funding. This initial support is often vital for researchers to establish proof of concept, making their projects more competitive for larger, multi-million-dollar grants from government bodies like the National Institutes of Health (NIH) in the future.

Beyond the Conventional: A Search for Radical Ideas

The explicit call for “innovative and imaginative proposals” is a direct response to the immense challenges posed by ALS. For decades, the disease’s complexity has stymied researchers. With no single definitive cause identified for the majority of cases and a diagnosis that is often difficult to make early, the need for new perspectives is urgent. Recent setbacks in clinical trials have further underscored the necessity of exploring entirely new pathways.

What constitutes a “bold” idea in this context? It means moving beyond incremental advances and challenging established paradigms. This could involve leveraging cutting-edge technologies like artificial intelligence and machine learning to analyze vast electronic health records, potentially identifying existing drugs that could be repurposed to treat ALS—a strategy already being explored at institutions like Lawrence Livermore National Laboratory. It also includes the development of novel biomarkers, such as noninvasive eye tests to detect the protein deposits that are a hallmark of the disease, which could revolutionize early diagnosis and clinical trial monitoring.

Furthermore, the initiative encourages applicants to build upon the wealth of data and resources already generated by the ALS community. The guidelines specifically prompt researchers to utilize existing collaborative platforms like ALL ALS, Project MiNE, and the Target ALS Cores. This directive aims to prevent redundant efforts and ensure new research adds to, rather than duplicates, the collective knowledge base, maximizing the value of every research dollar.

A New Beacon of Hope for the ALS Community

For the thousands of individuals and families living with the daily realities of an ALS diagnosis, research funding announcements are more than just news—they are a tangible symbol of progress and a vital source of hope. While the journey from a laboratory idea to a clinical treatment is long and uncertain, each new initiative represents a renewed commitment to finding solutions.

This funding opportunity is particularly significant because it prioritizes innovation, signaling to the community that the search for a cure is active on all fronts. The focus on patient-centric research is also a key, evolving trend. Increasingly, people with lived ALS experience, including patients, caregivers, and those at genetic risk, are involved in shaping research priorities and clinical trial design. This ensures that scientific exploration remains grounded in the real-world needs of those it aims to help.

The initiative from the ALS Network and ALS United fits into a larger, dynamic landscape of ALS research. It complements major federal efforts like the ACT for ALS Act, which aims to accelerate access to critical therapies, and the work of large non-profits and academic centers like the Sean M. Healey & AMG Center for ALS at Mass General. Each piece of this complex puzzle is essential. By providing nimble funding for novel concepts, this joint initiative fills a critical niche, nurturing the creative sparks that could ignite the next major breakthrough. The path forward is built on the collective determination of a community united in its mission, and this new fund is another powerful step on that journey.